SCHEMBL31366697

SCHEMBL31366697

NP(=O)(Oc1ccccc1)Oc1ccccc1.O=P(O)(O)N(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 2/20 0.48
LAP3 P28838 2/20 0.48
SRC P12931 1/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
HTT P42858 1/20 0.45
L3MBTL1 Q9Y468 3/20 0.43
TDP1 Q9NUW8 1/20 0.41
TSHR P16473 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KLK8 O60259 1/20 0.38
PLAU P00749 1/20 0.38
KLK2 P20151 1/20 0.38
KLK4 Q9Y5K2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8533599 0.83 HPGD (0.48) ANPEPLAP3MEN1KMT2ATSHR
SCHEMBL1395779 0.83 HPGD (0.48) ANPEPLAP3MEN1KMT2ATSHR
SCHEMBL31110322 0.81 TSHR (0.54) SRCKMT2ATDP1TSHRNPC1
SCHEMBL112831 0.77 MEN1 (0.60) ANPEPLAP3SRCMEN1KMT2A
SCHEMBL20549305 0.76 LAP3 (0.46) ANPEPLAP3TSHRNPC1RAB9A
SCHEMBL29902935 0.76 SRC (0.50) ANPEPLAP3SRCMEN1KMT2A
SCHEMBL28930389 0.72 CA2 (0.47) ANPEPLAP3TSHRNPC1RAB9A
SCHEMBL2852256 0.71 SRC (0.48) ANPEPLAP3SRCMEN1KMT2A
SCHEMBL9715447 0.70 SRC (0.47) ANPEPLAP3SRCMEN1KMT2A
SCHEMBL220525 0.69 SRC (0.67) ANPEPLAP3SRCL3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114945572-B HBF pharmacological inducing compounds for the treatment of sickle cell anemia and beta-thalassemia 周美吟 2025-01-28 CN disclosed